Table 1 Patient characteristics in the two groups
DataGroup 1Group 2
Sex (F/M)8/106/10
Age (years)43 (27–62)49 (34–66)
Duration of symptoms (months)24 (3–96)19 (4–60)
VAS (100 mm scale)*
    0 months68 (33–100)70 (32–88)
    3 months59 (13–97)54 (12–82)
    12 months36 (0–88)34 (0–95)
Maximum grip strength (kg)
    0 months37 (11–66)43 (10–68)
    3 months41 (12–68)42 (14–68)
    12 months47 (17–76)48 (24–74)
Satisfied with treatment (Yes/No)
    3 months9/910/6
    12 months14/413/3
  • VAS, visual analogue scale.

  • *0, No pain; 100, severe pain.

  • Group 1, polidocanol; group 2, lidocaine + epinephrine.

  • There were no significant differences between the groups.